Intercostal Nerve Cryotherapy in Patients Undergoing Minimally Invasive Pulmonary Resection

Randomized Trial of Intercostal Nerve Cryotherapy in Patients Undergoing Minimally Invasive Pulmonary Resection

This is a research study designed to test whether a treatment called Intercostal Nerve Cryotherapy is an effective way to help control post-surgical pain for patients undergoing minimally invasive pulmonary resection.

There are two treatment groups in this study, a cryotherapy group and control group. Cryotherapy is a method of controlling pain by freezing nerves between the ribs that would transmit pain impulses to the brain.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

110

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15212
        • Recruiting
        • AHN Allegheny General Hospital
        • Contact:
        • Sub-Investigator:
          • Hiran Fernando, MD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patients 18 year and older.
  2. Undergoing elective minimally invasive (VATS or robotic) lung resection for nodules (wedge resection, segmentectomy, lobectomy).
  3. Performance status of 1 or 2.

Exclusion Criteria:

  1. Patients with ejection fraction less than 40%
  2. Patients with creatinine greater than 1.5.
  3. Patients with Child's B or C cirrhosis
  4. Patients on chronic narcotics for other reasons
  5. Patients diagnosed with fibromyalgia
  6. Patients who had previous thoracic surgery on the same side.
  7. Patients who cannot communicate in English.
  8. Patients unable to provide informed consent for the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cryoanalgesia with standard of care pain control
subjects will receive standard of care pain control + cryoanalgesia in the intercostal spaces during routine surgery
intraoperative intercostal nerve freezing for post-operative pain control
Standard of Care Pain Control Post-operatively
Active Comparator: Standard of care pain control
subjects will receive standard of care pain control only
Standard of Care Pain Control Post-operatively

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total morphine dose
Time Frame: to discharge (up to 14 days)
total milligrams (mg) of morphine received during hospitalization
to discharge (up to 14 days)
Pain control
Time Frame: to discharge (up to 14 days)
Pain level, as assessed by visual analog scale (rating 0-10), with 0 being no pain to 10 being worst pain, with higher scores meaning a worse outcome
to discharge (up to 14 days)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pulmonary complications
Time Frame: through 1 year
Pulmonary complications as defined by the Society of Thoracic Surgeons database
through 1 year
pain control
Time Frame: 2 weeks and 3 months post-operatively
Pain level, as assessed by visual analog scale (rating 0-10), with 0 being no pain to 10 being worst pain, with higher scores meaning a worse outcome
2 weeks and 3 months post-operatively
total morphine equivalent dose of narcotics
Time Frame: 2 weeks and 3 months post-operatively
total dose (e.g. milligrams) assessed by the number of pills taken by patients postoperatively
2 weeks and 3 months post-operatively
Presence of neuropathy in the surgical site
Time Frame: 2 weeks, 3 months, 6 months and 1 year postoperatively

physician will assess by modified treatment-induced neuropathy scale (0-10), with higher scores meaning a worse outcome; The modified questionnaire will assess the following symptoms and ask patients to score those symptoms from 0 (not present) to 10 (unbearable):

  • Numbness at or near the incision site (including chest wall)
  • Tingling at or near the incision site
  • Pain at or near the incision site
  • Hot or burning sensation at or near the incision site
  • Feeling of coldness at or near the incision site
2 weeks, 3 months, 6 months and 1 year postoperatively
Incentive Spirometer Volume
Time Frame: to discharge (up to 14 days)
The highest number (breath volume) achieved on exhalation using the incentive spirometer
to discharge (up to 14 days)
Hospital length of stay
Time Frame: to discharge (up to 14 days)
Number of days spent in hospital postoperatively
to discharge (up to 14 days)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 21, 2022

Primary Completion (Estimated)

December 15, 2024

Study Completion (Estimated)

July 7, 2025

Study Registration Dates

First Submitted

April 15, 2022

First Submitted That Met QC Criteria

April 21, 2022

First Posted (Actual)

April 27, 2022

Study Record Updates

Last Update Posted (Estimated)

December 8, 2023

Last Update Submitted That Met QC Criteria

December 6, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Postoperative

Clinical Trials on cryoanalgesia

3
Subscribe